221 related articles for article (PubMed ID: 32841947)
21. FGF23-αKlotho as a paradigm for a kidney-bone network.
Kuro-O M; Moe OW
Bone; 2017 Jul; 100():4-18. PubMed ID: 27847255
[TBL] [Abstract][Full Text] [Related]
22. Effects of acute kidney injury and chronic hypoxemia on fibroblast growth factor 23 levels in pediatric cardiac surgery patients.
Hanudel MR; Wesseling-Perry K; Gales B; Ramos G; Campbell V; Ethridge K; Scotti M; Elashoff DA; Alejos J; Reemtsen B; Salusky IB
Pediatr Nephrol; 2016 Apr; 31(4):661-9. PubMed ID: 26525200
[TBL] [Abstract][Full Text] [Related]
23. Fibroblast Growth Factor 23 and Osteoporosis: Evidence from Bench to Bedside.
Sirikul W; Siri-Angkul N; Chattipakorn N; Chattipakorn SC
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269640
[TBL] [Abstract][Full Text] [Related]
24. Role of Fibroblast Growth Factor 23 (FGF23) and αKlotho in Cancer.
Ewendt F; Feger M; Föller M
Front Cell Dev Biol; 2020; 8():601006. PubMed ID: 33520985
[TBL] [Abstract][Full Text] [Related]
25. Dysregulated Mineral Metabolism in AKI.
Leaf DE; Christov M
Semin Nephrol; 2019 Jan; 39(1):41-56. PubMed ID: 30606407
[TBL] [Abstract][Full Text] [Related]
26. Fibroblast growth factor 23, endothelium biomarkers and acute kidney injury in critically-ill patients.
de Oliveira Neves FM; Araújo CB; de Freitas DF; Arruda BFT; de Macêdo Filho LJM; Salles VB; Meneses GC; Martins AMC; Libório AB
J Transl Med; 2019 Apr; 17(1):121. PubMed ID: 30971270
[TBL] [Abstract][Full Text] [Related]
27. The demonstration of αKlotho deficiency in human chronic kidney disease with a novel synthetic antibody.
Barker SL; Pastor J; Carranza D; Quiñones H; Griffith C; Goetz R; Mohammadi M; Ye J; Zhang J; Hu MC; Kuro-o M; Moe OW; Sidhu SS
Nephrol Dial Transplant; 2015 Feb; 30(2):223-33. PubMed ID: 25324355
[TBL] [Abstract][Full Text] [Related]
28. A unique FGF23 with the ability to activate FGFR signaling through both αKlotho and βKlotho.
Wu X; Weiszmann J; Ge H; Baribault H; Stevens J; Hawkins N; Vonderfecht S; Gardner J; Gupte J; Sheng J; Wang M; Li Y
J Mol Biol; 2012 Apr; 418(1-2):82-9. PubMed ID: 22370560
[TBL] [Abstract][Full Text] [Related]
29. Clinical Potential of Targeting Fibroblast Growth Factor-23 and αKlotho in the Treatment of Uremic Cardiomyopathy.
Law JP; Price AM; Pickup L; Radhakrishnan A; Weston C; Jones AM; McGettrick HM; Chua W; Steeds RP; Fabritz L; Kirchhof P; Pavlovic D; Townend JN; Ferro CJ
J Am Heart Assoc; 2020 Apr; 9(7):e016041. PubMed ID: 32212912
[TBL] [Abstract][Full Text] [Related]
30. αKlotho deficiency in acute kidney injury contributes to lung damage.
Ravikumar P; Li L; Ye J; Shi M; Taniguchi M; Zhang J; Kuro-o M; Hu MC; Moe OW; Hsia CC
J Appl Physiol (1985); 2016 Apr; 120(7):723-32. PubMed ID: 26718784
[TBL] [Abstract][Full Text] [Related]
31. Plasma FGF23 levels increase rapidly after acute kidney injury.
Christov M; Waikar SS; Pereira RC; Havasi A; Leaf DE; Goltzman D; Pajevic PD; Wolf M; Jüppner H
Kidney Int; 2013 Oct; 84(4):776-85. PubMed ID: 23657144
[TBL] [Abstract][Full Text] [Related]
32. Erythropoietin induces bone marrow and plasma fibroblast growth factor 23 during acute kidney injury.
Toro L; Barrientos V; León P; Rojas M; Gonzalez M; González-Ibáñez A; Illanes S; Sugikawa K; Abarzúa N; Bascuñán C; Arcos K; Fuentealba C; Tong AM; Elorza AA; Pinto ME; Alzamora R; Romero C; Michea L
Kidney Int; 2018 May; 93(5):1131-1141. PubMed ID: 29395333
[TBL] [Abstract][Full Text] [Related]
33. Localization of fibroblast growth factor 23 protein in the rat hypothalamus.
Ursem SR; Diepenbroek C; Bacic V; Unmehopa UA; Eggels L; Maya-Monteiro CM; Heijboer AC; la Fleur SE
Eur J Neurosci; 2021 Aug; 54(4):5261-5271. PubMed ID: 34184338
[TBL] [Abstract][Full Text] [Related]
34. Endocrine fibroblast growth factors as potential biomarkers for chronic kidney disease.
Kondo Y; Komaba H; Fukagawa M
Expert Rev Mol Diagn; 2020 Jul; 20(7):715-724. PubMed ID: 32513031
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-6 contributes to the increase in fibroblast growth factor 23 expression in acute and chronic kidney disease.
Durlacher-Betzer K; Hassan A; Levi R; Axelrod J; Silver J; Naveh-Many T
Kidney Int; 2018 Aug; 94(2):315-325. PubMed ID: 29861060
[TBL] [Abstract][Full Text] [Related]
36. Plasma total fibroblast growth factor 23 levels are associated with acute kidney injury and mortality in children with acute respiratory distress syndrome.
Hanudel MR; Zinter MS; Chen L; Gala K; Lim M; Guglielmo M; Deshmukh T; Vangala S; Matthay M; Sapru A
PLoS One; 2019; 14(9):e0222065. PubMed ID: 31487315
[TBL] [Abstract][Full Text] [Related]
37. Fibroblast growth factor-23 and the long-term risk of hospital-associated AKI among community-dwelling older individuals.
Brown JR; Katz R; Ix JH; de Boer IH; Siscovick DS; Grams ME; Shlipak M; Sarnak MJ
Clin J Am Soc Nephrol; 2014 Feb; 9(2):239-46. PubMed ID: 24262510
[TBL] [Abstract][Full Text] [Related]
38. The FGF23/KLOTHO Regulatory Network and Its Roles in Human Disorders.
Kinoshita S; Kawai M
Vitam Horm; 2016; 101():151-74. PubMed ID: 27125741
[TBL] [Abstract][Full Text] [Related]
39. Fibroblast growth factor 23/klotho axis in chronic kidney disease.
Nitta K; Nagano N; Tsuchiya K
Nephron Clin Pract; 2014; 128(1-2):1-10. PubMed ID: 25402964
[TBL] [Abstract][Full Text] [Related]
40. [Discovery of alpha-Klotho and FGF23 unveiled new insight into calcium and phosphate homeostasis].
Nabeshima Y
Clin Calcium; 2008 Jul; 18(7):923-34. PubMed ID: 18591743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
